Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?
Authors
Mongey, AB et al.Affiliation
Our Lady's Hospice & Care ServicesIssue Date
2009Keywords
RHEUMATOLOGYHOSPICE
Local subject classification
MUSCULOSKELETAL CARELUPUS
Metadata
Show full item recordCitation
Lupus, vol 18, issue 2, pp.169-71Journal
LupusPubMed ID
19151120Additional Links
http://www.ncbi.nlm.nih.gov/pubmed?term=19151120Item Type
ArticleLanguage
enCollections
Related articles
- Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
- Authors: Mañosa M, Domènech E, Marín L, Olivé A, Zabana Y, Cabré E, Gassull MA
- Issue date: 2008 Apr
- [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
- Authors: Benucci M, Nenci G, Cappelletti C, Manfredi M
- Issue date: 2008 Jul-Aug
- Drug-induced lupus due to anti-tumor necrosis factor alpha agents.
- Authors: Costa MF, Said NR, Zimmermann B
- Issue date: 2008 Jun
- Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
- Authors: van Rijthoven AW, Bijlsma JW, Canninga-van Dijk M, Derksen RH, van Roon JA
- Issue date: 2006 Oct
- Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab.
- Authors: Verma HD, Scherl EJ, Jacob VE, Bosworth BP
- Issue date: 2011 Oct